Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024970 · ClinicalTrials.gov registry record · NA
Daily Disposable Dispensing Clinical Trial of Test Lens Against Stenfilcon A Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03024970 is a NA study that has completed, run by CooperVision. The registered enrollment target is 72 participants.
The verdict
NCT03024970, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the overall clinical performance of the test daily disposable stenfilcon A lens with solution additive (test) compared to the stenfilcon A lens (control).
Interventions
- DEVICE stenfilcon A lens (control)
- DEVICE stenfilcon A lens with solution additive (test)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024970
The ClinicalTrials.gov registry entry for NCT03024970 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stenfilcon A lens (control) is the first listed.
NCT03024970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03024970 about?
NCT03024970 is a clinical study titled "Daily Disposable Dispensing Clinical Trial of Test Lens Against Stenfilcon A Lens". The purpose of this study is to investigate the overall clinical performance of the test daily disposable stenfilcon A lens with solution additive (test) compared to the stenfilcon A lens (control).
What is the current status of trial NCT03024970?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2017-01. Estimated completion is 2017-06-26.
What interventions are being tested in trial NCT03024970?
The interventions under investigation include: stenfilcon A lens (control) (DEVICE), stenfilcon A lens with solution additive (test) (DEVICE).
Who is sponsoring clinical trial NCT03024970?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.